Accounting for Zimmer spin-off
This article was originally published in The Gray Sheet
Executive Summary
Bristol-Myers Squibb's March 10 earnings restatement release reports that contingency funds associated with the August 2001 spin-off of its orthopedics unit were "determined to be in excess and reversed into other income.... Accordingly, the company has reversed the establishment of these liabilities"...